Published in Crit Care on June 11, 2008
Adjunct corticosteroids in children hospitalized with community-acquired pneumonia. Pediatrics (2011) 1.64
Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations. Lung India (2012) 1.40
Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial. Crit Care (2011) 1.30
Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia. Crit Care (2010) 1.06
Organizing pneumonia in patients with severe respiratory failure due to novel A (H1N1) influenza. BMJ Case Rep (2010) 0.98
Common NFKBIL2 polymorphisms and susceptibility to pneumococcal disease: a genetic association study. Crit Care (2010) 0.86
Glucocorticosteroid in treatment of severe pneumonia. Mediators Inflamm (2013) 0.79
Defining and predicting severe community-acquired pneumonia. Curr Opin Infect Dis (2010) 0.78
Defining severe pneumonia. Clin Chest Med (2011) 0.77
Corticosteroids in severe community-acquired pneumonia: the path we choose depends on where we want to get. Crit Care (2011) 0.75
Corticosteroids for community-acquired pneumonia: time to act! Crit Care (2008) 0.75
Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med (2001) 51.99
Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med (2001) 27.70
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis (2007) 24.91
A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med (1997) 24.87
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA (2002) 16.37
Hydrocortisone therapy for patients with septic shock. N Engl J Med (2008) 15.85
Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med (2008) 5.30
An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med (2006) 5.29
Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med (1998) 5.22
Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med (2004) 4.58
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care (2007) 3.80
Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med (2005) 3.09
C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest (2003) 2.95
Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med (2006) 2.69
Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med (2002) 2.52
Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ (2004) 2.39
Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med (1998) 1.99
Such stuff as dreams are made on: mediator-directed therapy in sepsis. Nat Rev Drug Discov (2003) 1.92
Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia. A randomized controlled study. Chest (1993) 1.74
Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med (2002) 1.52
C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J (2005) 1.49
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection. Cochrane Database Syst Rev (2006) 1.46
Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest (1987) 1.43
Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia. Clin Diagn Lab Immunol (2003) 1.31
Effects of systemic steroids in patients with severe community-acquired pneumonia. Eur Respir J (2007) 1.20
Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database. Crit Care (2006) 1.19
Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course. Crit Care (2007) 1.19
Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization. Lung (2007) 1.19
Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia. Am J Respir Crit Care Med (2007) 1.15
Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study. Eur Respir J (1999) 1.12
Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation. Haematologica (2002) 1.01
The hospital management of community-acquired pneumonia. Recommendations of the British Thoracic Society. J R Coll Physicians Lond (1987) 1.01
Recent advances in community-acquired pneumonia: inpatient and outpatient. Chest (2007) 0.96
Cortisol levels in patients with severe community-acquired pneumonia. Intensive Care Med (2006) 0.90
Influence of steroids on procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia. Infection (2008) 0.88
Beyond sepsis pathophysiology with cytokines: what is their value as biomarkers for disease severity? Mem Inst Oswaldo Cruz (2005) 0.86
Systemic inflammatory response after bronchoalveolar lavage in critically ill patients. Eur Respir J (2001) 0.84
Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study. Crit Care Med (2010) 3.83
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care (2007) 3.80
Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza. Sci Transl Med (2010) 3.02
Organizational characteristics, outcomes, and resource use in 78 Brazilian intensive care units: the ORCHESTRA study. Intensive Care Med (2015) 2.92
RIFLE classification in patients with acute kidney injury in need of renal replacement therapy. Intensive Care Med (2007) 2.71
A central role for free heme in the pathogenesis of severe sepsis. Sci Transl Med (2010) 2.54
Outcomes of critically ill patients with acute kidney injury and end-stage renal disease requiring renal replacement therapy: a case-control study. Nephrol Dial Transplant (2009) 2.26
Delirium epidemiology in critical care (DECCA): an international study. Crit Care (2010) 2.07
Mycobacterium bovis bacillus Calmette-Guérin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis in vivo. J Immunol (2006) 1.87
Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood (2013) 1.74
Critically ill patients with cancer and sepsis: clinical course and prognostic factors. J Crit Care (2011) 1.72
Access to urban acute care services in high- vs. middle-income countries: an analysis of seven cities. Intensive Care Med (2013) 1.64
Delirium recognition and sedation practices in critically ill patients: a survey on the attitudes of 1015 Brazilian critical care physicians. J Crit Care (2009) 1.54
Methylprednisolone improves lung mechanics and reduces the inflammatory response in pulmonary but not in extrapulmonary mild acute lung injury in mice. Crit Care Med (2008) 1.49
Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams. Crit Care (2011) 1.48
Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis. Shock (2004) 1.36
Bioenergetic failure of human peripheral blood monocytes in patients with septic shock is mediated by reduced F1Fo adenosine-5'-triphosphate synthase activity. Crit Care Med (2011) 1.33
Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients. Crit Care (2010) 1.30
Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular Loci involved in eicosanoid metabolism. J Immunol (2002) 1.22
Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release. Shock (2004) 1.21
Sepsis induces brain mitochondrial dysfunction. Crit Care Med (2008) 1.21
Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course. Crit Care (2007) 1.19
Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection. FASEB J (2009) 1.19
Positive end-expiratory pressure at minimal respiratory elastance represents the best compromise between mechanical stress and lung aeration in oleic acid induced lung injury. Crit Care (2007) 1.19
Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. PLoS Pathog (2010) 1.18
Lipid bodies in inflammatory cells: structure, function, and current imaging techniques. J Histochem Cytochem (2011) 1.17
Induction of autophagy correlates with increased parasite load of Leishmania amazonensis in BALB/c but not C57BL/6 macrophages. Microbes Infect (2008) 1.16
Calcitonin gene-related peptide inhibits local acute inflammation and protects mice against lethal endotoxemia. Shock (2005) 1.14
Systemic inflammatory response syndrome and multiple organ dysfunction in patients with acute tumor lysis syndrome. Clinics (Sao Paulo) (2009) 1.13
Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria. PLoS Pathog (2012) 1.11
C-reactive protein in critically ill cancer patients with sepsis: influence of neutropenia. Crit Care (2011) 1.10
Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis. Shock (2006) 1.09
Host cell lipid bodies triggered by Trypanosoma cruzi infection and enhanced by the uptake of apoptotic cells are associated with prostaglandin E₂ generation and increased parasite growth. J Infect Dis (2011) 1.08
Cortisol levels and adrenal response in severe community-acquired pneumonia: a systematic review of the literature. J Crit Care (2010) 1.07
H1N1pdm influenza infection in hospitalized cancer patients: clinical evolution and viral analysis. PLoS One (2010) 1.07
Neutrophils recruited to the site of Mycobacterium bovis BCG infection undergo apoptosis and modulate lipid body biogenesis and prostaglandin E production by macrophages. Cell Microbiol (2008) 1.07
Trials of biomarker-guided antimicrobial therapy in sepsis: improvements in trial design require better control groups. Crit Care Med (2014) 1.06
Comparison of CAM-ICU and ICDSC for the detection of delirium in critically ill patients focusing on relevant clinical outcomes. J Crit Care (2011) 1.05
Role of monocyte chemotactic protein-1/CC chemokine ligand 2 on gamma delta T lymphocyte trafficking during inflammation induced by lipopolysaccharide or Mycobacterium bovis bacille Calmette-Guérin. J Immunol (2003) 1.05
The predisposition, infection, response and organ failure (Piro) sepsis classification system: results of hospital mortality using a novel concept and methodological approach. PLoS One (2013) 1.04
Increased Leishmania replication in HIV-1-infected macrophages is mediated by tat protein through cyclooxygenase-2 expression and prostaglandin E2 synthesis. J Infect Dis (2006) 1.03
IFN-gamma production by CD8+ T cells depends on NFAT1 transcription factor and regulates Th differentiation. J Immunol (2005) 1.03
Lutzomyia longipalpis saliva triggers lipid body formation and prostaglandin E₂ production in murine macrophages. PLoS Negl Trop Dis (2010) 1.02
The role of Nox2-derived ROS in the development of cognitive impairment after sepsis. J Neuroinflammation (2014) 1.01
Two-dimensional difference gel electrophoresis (DiGE) analysis of plasmas from dengue fever patients. J Proteome Res (2009) 1.01
Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: a cohort study. J Crit Care (2011) 1.01
Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study. Crit Care (2012) 1.00
Evidence that lipopolisaccharide may contribute to the cytokine storm and cellular activation in patients with visceral leishmaniasis. PLoS Negl Trop Dis (2011) 0.99
Lipid bodies in oxidized LDL-induced foam cells are leukotriene-synthesizing organelles: a MCP-1/CCL2 regulated phenomenon. Biochim Biophys Acta (2009) 0.99
Inflammation biomarkers and delirium in critically ill patients. Crit Care (2014) 0.98
ICU severity of illness scores: APACHE, SAPS and MPM. Curr Opin Crit Care (2014) 0.97
Cutaneous periumbilical purpura in disseminated strongyloidiasis in cancer patients: a pathognomonic feature of potentially lethal disease? Braz J Infect Dis (2006) 0.97
Bone marrow-derived mononuclear cell therapy in experimental pulmonary and extrapulmonary acute lung injury. Crit Care Med (2010) 0.96
Allergic challenge-elicited lipid bodies compartmentalize in vivo leukotriene C4 synthesis within eosinophils. Am J Respir Cell Mol Biol (2005) 0.95
Lutzomyia longipalpis saliva drives apoptosis and enhances parasite burden in neutrophils. J Leukoc Biol (2011) 0.95
Should C-reactive protein concentration at ICU discharge be used as a prognostic marker? BMC Anesthesiol (2010) 0.95
Bacterial clearance in septic mice is modulated by MCP-1/CCL2 and nitric oxide. Shock (2013) 0.94
An urban perspective on sepsis in developing countries. Lancet Infect Dis (2010) 0.93
Cutting edge: prostaglandin D2 enhances leukotriene C4 synthesis by eosinophils during allergic inflammation: synergistic in vivo role of endogenous eotaxin. J Immunol (2006) 0.92
Clinical Manifestations of Zika Virus Infection, Rio de Janeiro, Brazil, 2015. Emerg Infect Dis (2016) 0.92
Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein. J Immunol (2002) 0.92
Eosinophils as a novel cell source of prostaglandin D2: autocrine role in allergic inflammation. J Immunol (2011) 0.91